BYAH · Park Ha Biological Technology Co., Ltd.
Market Cap
$2.24M
Shares
795,527
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.52M
+6%
FY2025
Net Income
-$24.36M
-5191.3%
FY2025
Gross Margin
94.36%
+2.6pp
FY2025
Operating Margin
-956.45%
-989.8pp
FY2025
Diluted EPS
-$331.04
-4410.4%
FY2025
Operating Cash Flow
$85.85K
-91.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| $2.52M | $2.38M | $2.46M | $1.92M | |
| $142.53K | $195.34K | $310.99K | $509.16K | |
| $2.38M | $2.19M | $2.15M | $1.41M | |
| 94.36% | 91.8% | 87.35% | 73.47% | |
| $238.18K | $36.71K | $30.88K | $60.67K | |
| $625.29K | $361.33K | $299.62K | $438.6K | |
| $25.48M | $814.86K | $484.96K | $707.49K | |
| $970 | $974 | $992 | — | |
| $109.37K | $22.69K | $20.06K | $30.49K | |
| $26.53M | $1.39M | $967.56K | $1.21M | |
| -$24.15M | $793.71K | $1.18M | $197.02K | |
| -956.45% | 33.32% | 48.01% | 10.26% | |
| -$24.04M | $816.4K | $1.2M | $227.52K | |
| $41 | — | — | $194 | |
| $6097 | $783 | $1590 | $263 | |
| $64.79K | -$293 | $1015 | -$7014 | |
| -$24.08M | $793.42K | $1.18M | $190.01K | |
| $280.65K | $314.86K | $329.53K | -$1288 | |
| -$24.36M | $478.56K | $852.04K | $191.3K | |
| -965% | 20.09% | 34.65% | 9.97% | |
| -$24.37M | $493.11K | $823.93K | $194.31K | |
| USD/shares | -$331.04 | $7.68 | $13.60 | $4.00 |
| USD/shares | -$331.04 | $7.68 | $13.60 | $4.00 |
| shares | 73.61K | 62.5K | 62.5K | 62.5K |
| shares | 73.61K | 62.5K | 62.5K | 62.5K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Franchise Fees | $1,510,809 | $1,674,620 | $1,810,357 | $937,554 |
| Products Sales Nonfranchisees | $535,760 | $355,832 | $302,505 | $334,419 |
| Product Sales Franchisees | $478,274 | $351,399 | $346,240 | $647,416 |
Key facts
CIK
1986247
CUSIP
G6925R110
13F (30d)
4 filings
4 filers